Navigation Links
European Pharmaceutical and Biotech Contract Manufacturing Markets
Date:2/6/2012

NEW YORK, Feb. 6, 2012  /PRNewswire/ --  Reportlinker.com announces that a new market research report is available in its catalogue:

European Pharmaceutical and Biotech Contract Manufacturing Markets

http://www.reportlinker.com/p0769017/European-Pharmaceutical-and-Biotech-Contract-Manufacturing-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Manufacturing

The Research Service offers analysis and assessment of the European Pharmaceutical and Biotech Contract Manufacturing Markets, maps the key trends and dynamics shaping the industry sector, and provides strategic recommendations for the success of the market participants. This study provides an in-depth analysis of the Pharmaceutical Contract Manufacturing Market in terms of Solids, Liquids, and Injectables finished dose formulations; and the Biotech Contract Manufacturing Market, in terms of Mammalian and Microbial cell culture based products, with a specific focus on the key five countries in Europe - Germany, France, the United Kingdom, Italy, and Spain.

Table of Contents Introduction 4

Executive Summary 8

Market Overview 12

European Pharmaceutical and Biotech Contract Manufacturing Markets -

External Challenges, Drivers and Restraints - Total Market 17

Market Trends and Technology Trends 33

Competitive Landscape Analysis 47

Regulatory Analysis 50

European Pharmaceutical Contract Manufacturing Market 56

Revenue Forecast Analysis - European Pharmaceutical Contract Manufacturing Market 63

Competitive Landscape Analysis - European Pharmaceutical Contract Manufacturing Market 76

Country Breakdown - European Pharmaceutical Contract Manufacturing Market 104

The Last Word - Eur
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
6. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
9. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
10. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
11. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ), ... commercialization of products for central nervous system disorders, ... at the Society for Research on Biological Rhythms ... The first poster entitled Pleiomorphic Expression of ... insight into the challenges faced by individuals suffering ...
(Date:5/22/2012)... ALLEGAN, Mich., May 22, 2012  Perrigo Company ... final approval from the U.S. Food and Drug ... for butoconazole nitrate 2% vaginal cream, the generic ... submit a substantially complete ANDA with a paragraph ... marketing exclusivity. Perrigo is working exclusively with KV Pharmaceutical ...
(Date:5/22/2012)... Generics, a division of Prodigy Health Supplier Corporation ... generic equivalent of the branded drug Camptosar by ... Laboratories to develop a portfolio of oncology products. ... developed through the partnership that will add consistent ... market, which has experienced record levels of shortages ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 1GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 2GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 4ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 1ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 1MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 3MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 4
... Harvard Pilgrim achieves CORE Phase II Testing Certification with ... that are now required in X12 Version 5010BELLEVUE, Wash., ... it will, together with its partners CAQH and Harvard ... from the CORE Phase II Certification testing including elements ...
... Novo Nordisk today announced that the Endocrinologic and Metabolic Drugs ... (FDA) has finalized its discussions of questions related to liraglutide, ... questions related to the risk profile of liraglutide. , ... A majority of Advisory Committee members supported that ...
Other Medicine Technology:Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 2Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 3Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 4Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 5Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 2Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes 3
(Date:5/23/2012)... second edition of Law and the American Health Care ... 2012. Building on its 1997 predecessor, the second edition ... intersection of law and the U.S. health care system. ... a time of unprecedented change in how health care ... of study, the book focuses on how a dramatically ...
(Date:5/23/2012)... of the same kind, thereby triggering skeletal and cardiac ... from the RUB Heart and Diabetes Center NRW in ... an interdisciplinary research project with colleagues from the universities ... Journal of Biological Chemistry . , One ... stabilizing filaments inside of the cells. Different mutations in ...
(Date:5/23/2012)... FRANCISCO The number of viral infections during infancy ... to a new study from researchers in the Netherlands. ... later in childhood, this association was due in part ... in infancy, particularly rhinovirus, are thought to be a ... unclear whether this association is due to the viruses ...
(Date:5/23/2012)... present findings on prostate cancer risk, screening, treatment ... of the American Urological Association May 19-23 in ... to provide expert comment for reporters covering the ... presented and their embargo dates include: , ... surgery hormone therapy , Embargoed until 10:30 a.m. ...
(Date:5/22/2012)... MAYWOOD, Ill. -- Children born with cleft lip, ... medical challenges beyond appearance. , Patients can face ... well as social and psychological challenges, Laura Swibel ... colleagues write in the June 2012 issue of ... "The management of patients with craniofacial syndromes is ...
Breaking Medicine News(10 mins):Health News:Landmark textbook on health care and the US legal system released 2Health News:Aggregating instead of stabilizing: New insights into the mechanisms of heart disease 2Health News:Viral infections in infancy are not associated with wheezing symptoms in later childhood 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 2Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 3Health News:Mayo Clinic urologists present findings at American Urological Association Annual Meeting 4Health News:Cleft lip/palate cause much more than cosmetic problems 2
... SPRINGS, Fla., June 2 Boca Pharmacal, Inc.,announced ... has granted,final approval for the Company,s Abbreviated New ... Pamlab,s Palgic(R) 4mg Tablet (Carbinoxamine,Maleate 4 mg Tablet). ... Carbinoxamine Maleate 4mg Tablet is indicated to ...
... Featuring Live Performances by The Who and Tribute,Bands Pearl Jam, Foo ... July 17 at 9:00pm* from the Pauley Pavilion ... first time ever, fans will,have the opportunity to see some of ... on sale for the network,s third annual "VH1 Rock,Honors" event paying ...
... performance determines ranking as second fastest growing ... ... Dynamics Company,Ltd.) (TSX: IDL), the global leader in the rapidly growing ... Canada,s,sixth fastest growing company in the 20th annual PROFIT 100 by ...
... first-line drug for type 2 diabetes, may be effective ... with early stage breast cancer who took the drug ... for further research of the drug as a potential ... Texas M. D. Anderson Cancer Center. , The retrospective ...
... June 2 The following event,announcement was released ... Epidemiology:, WHAT:, Association for Professionals in ... and International Meeting, WHEN:, Sunday - ... Convention Center, Denver, CO, 700 14th Street ...
... June 2 The New Jersey,Hospital Association this ... counsel, NJHA,s president-designee Betsy Ryan announced., Jacobs, ... Ali,who has been named NJHA,s vice president of ... will provide direction on all legal matters,to NJHA ...
Other Medicine News:Health News:'VH1 Rock Honors: The Who' Tickets Go on Sale Sunday, June 8 with Proceeds to Benefit the Efforts of Multiple Charities 2Health News:'VH1 Rock Honors: The Who' Tickets Go on Sale Sunday, June 8 with Proceeds to Benefit the Efforts of Multiple Charities 3Health News:'VH1 Rock Honors: The Who' Tickets Go on Sale Sunday, June 8 with Proceeds to Benefit the Efforts of Multiple Charities 4Health News:'VH1 Rock Honors: The Who' Tickets Go on Sale Sunday, June 8 with Proceeds to Benefit the Efforts of Multiple Charities 5Health News:IDC ranked no. 6 of Canada's 100 fastest growing companies by PROFIT Magazine 2Health News:IDC ranked no. 6 of Canada's 100 fastest growing companies by PROFIT Magazine 3Health News:Metformin increases pathologic complete response rates in breast cancer patients with diabetes 2
... have been designed to optimize the accuracy ... our tip products is widely recognized by ... has been extended over the years and ... and special tips including filter tips, certified ...
... Tips offer a safe alternative to using ... for applications such as PCR(a), pipetting radioactive ... Tips are excellent for tissue culture, gel ... Tips prevent aerosol contaminants and liquids from ...
... 3000 combines a powerful motor with a ... nozzle rotates to three positions for maximum ... the nozzle release button on the top ... nozzle position. The wide-angle position is ideal ...
... Peroxidase stain is the gold standard ... better agreement with your technologists manual ... efficiency. ,True RBC morphology advances cell ... allows for the differentiation of various ...
Medicine Products: